Announcement of Jinyao Pharmaceutical Co., Ltd. on the acquisition of the FDA DMF First Medication Letter for difukert APIs
Notice of Tianjin Pharmaceutical Co., Ltd. on convening the 2nd Extraordinary General Meeting of Shareholders in 2024
Announcement of Jinyao Pharmaceutical Co., Ltd. on participating in the 2024 semi-annual report performance briefing session of listed companies in Tianjin and online investor reception day
Announcement of Tianjin Pharmaceutical Co., Ltd. on the subsidiary obtaining a drug registration certificate
Announcement of Tianjin Pharmaceutical Co., Ltd. on changing employee supervisors
Announcement of Tianjin Pharmaceutical Co., Ltd. on preparation for impairment
Announcement by Tianjin Tyan Pharmaceuticals Co., Ltd. on its subsidiary's pharmaceuticals passing the generic drug consistency evaluation.
Announcement by Tianjin Tyan Pharmaceuticals Co., Ltd. on its subsidiary's pharmaceuticals passing the generic drug consistency evaluation.
Announcement on Tianjin Tianyao Pharmaceuticals Co., Ltd.'s subsidiary adding new specifications for pharmaceutical products and passing the consistency evaluation of generic drugs.
Announcement of Tianjin Tianyao Pharmaceuticals Co., Ltd.'s revision of the Company's Articles of Association and completion of business registration changes.
Announcement from Tianjin Tianyao Pharmaceuticals regarding the receipt of approval notification for the listing application of chemical raw materials active pharmaceutical ingredient.
Announcement of Tianjin Tianyao Pharmaceuticals Co., Ltd. regarding the application for loans by pledging its own assets by its subsidiary and related transactions
Announcement of Tianjin Tianyao Pharmaceuticals Co., Ltd. regarding Provision for Asset Impairment
Announcement of Tianjin Pharmaceutical Co., Ltd. on preparation for impairment
Announcement of Tianjin Pharmaceutical Co., Ltd. on the subsidiary obtaining a drug registration certificate
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Tianjin Pharmaceutical Co., Ltd.
Legal Opinion of Tianjin Changshi Law Firm on the 2023 Annual General Meeting of Shareholders of Tianjin Pharmaceutical
Announcement of Tianjin Pharmaceutical Co., Ltd. on the subsidiary obtaining a drug registration certificate
Materials of the 2023 Annual General Meeting of Shareholders of Tianjin Pharmaceutical Co., Ltd.
Notice of Jinyao Pharmaceutical Co., Ltd. on convening the 2023 Annual General Meeting of Shareholders
No Data